| Title |
Excerpt |
Author |
Date |
Total Comments |
Recent Comment |
| Bevacizumab for breast cancer: FDA grants a stay of execution |
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision. |
Dr. A. De la Guerra |
01/19/11 |
0 |
|
| New TNM Classification for Lung Cancer. Part II: A review |
The American Joint Committee on Cancer and the Union Internationale Contre le Cancer have redefined the criteria for staging lung cancer based on the proposals made by the International Association for the Study of Lung Cancer, which appeared in the recently launched 7th edition of the TNM system. This article… |
Dr. A. De la Guerra |
02/07/10 |
6 |
03/01/10 |
| New TNM Classification for Lung Cancer - Part I: The changes |
Appropriate staging of lung cancer is fundamental for determining the best treatment approach and defining prognosis. After ten years of labor the IASLC has modernized the lung cancer TNM staging system. Revisions to the TNM were determined by differences in the overall survival of 81,015 patients; after meticulous validation the… |
Dr. A. De la Guerra |
02/01/10 |
0 |
|